Gentel plans to add 50 new kits to its product portfolio by the end of the year, as it transforms itself from being a services-oriented business to one that derives the bulk of its sales from products.
The collaboration covers Protein Biotechnologies' SomaPlex arrays and Gentel Bioscience's APiX View Detection Kits, which were launched this week.
Illumina's VeraCode ADME Core Panel, Aushon Biosystems' human vascular injury panels, BioServe and Protein Biotechnologies' SomaPlex reverse-phase protein microarrays
The SomaPlex Reverse Phase Protein Microarray is the first product stemming from a collaboration between the two firms, and additional arrays are planned for launch throughout 2010.
University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.
A new study of a β-thalassemia gene therapy appears promising, according to NPR.
In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.
Futurism writes that gene doping could be the next generation of cheating in sports.